Immediate Impact
45 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Bioactive compound encapsulation: Characteristics, applications in food systems, and implications for human health
2024 Standout
Works of Roxanne Quinn being referenced
Phase II Study of the WEE1 Inhibitor Adavosertib in Recurrent Uterine Serous Carcinoma
2021
Combined pembrolizumab and pegylated liposomal doxorubicin in platinum resistant ovarian cancer: A phase 2 clinical trial
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Roxanne Quinn | 88 | 122 | 40 | 67 | 9 | 234 | |
| Vanessa Costa Miranda | 134 | 143 | 30 | 71 | 11 | 289 | |
| Saira Khalique | 106 | 71 | 23 | 92 | 11 | 187 | |
| Genevieve Dall | 73 | 131 | 40 | 19 | 10 | 259 | |
| Dan-Arin Silasi | 44 | 79 | 21 | 37 | 7 | 183 | |
| Junde Zhao | 144 | 84 | 50 | 35 | 13 | 283 | |
| Ilian Tchakov | 71 | 146 | 31 | 61 | 12 | 208 | |
| P.J. O'Donovan | 147 | 67 | 12 | 47 | 10 | 270 | |
| Melanie Polin | 75 | 32 | 25 | 20 | 11 | 189 | |
| Danielle D. Jandial | 76 | 95 | 15 | 28 | 7 | 213 | |
| Elizabeth V. Connor | 52 | 44 | 19 | 26 | 10 | 150 |
All Works
Login with ORCID to disown or claim papers
Loading papers...